𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy

✍ Scribed by Jerry L. Barker; Eleanor D. Montague; Lester J. Peters


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
440 KB
Volume
45
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Extended-field radiotherapy and high–dos
✍ Brij M. Sood; Giridhar R. Gorla; Madhur Garg; Patrick S. Anderson; Abbie L. Fiel πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

## Abstract ## BACKGROUND It has long been recognized that many patients with locally advanced carcinoma of the cervix harbor occult paraaortic metastases. A randomized study demonstrated that elective paraaortic irradiation improved survival and reduced distant metastases. More recently, concomit

Prognosis of dermal lymphatic invasion w
✍ Guenther Gruber; Michele Ciriolo; Hans Joerg Altermatt; Stefan Aebi; Gilles Berc πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 202 KB

It is still an open debate whether tumor emboli in dermal lymphatics without inflammatory signs represent a similar bad prognosis like inflammatory breast cancer. We evaluated the prognostic role of dermal lymphatic invasion (DLI) in breast cancer with (DLI + ID) or without (DLI w/o ID) inflammatory

Radical vulvectomy combined with electiv
✍ James W. Daly; Rodney R. Million πŸ“‚ Article πŸ“… 1974 πŸ› John Wiley and Sons 🌐 English βš– 420 KB πŸ‘ 1 views

T h e conventional treatment for squamous carcinoma of the vulva with negative nodes (No) is radical vulvectomy and bilateral node dissections. Approximately 20-3096 of No p-atients will have involved nodes in the surgical specimen. The morbidity/mortality added by the node dissections may be consi

The cost of adjuvant chemotherapy in pat
✍ Nina Oestreicher; Scott D. Ramsey; Jeannine S. McCune; Hannah M. Linden; David L πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Abstract ## BACKGROUND In the U.S., the majority of premenopausal patients with early‐stage breast carcinoma are treated with adjuvant chemotherapy. However, to the authors' knowledge, there have been few formal analyses of adjuvant chemotherapy cost performed to date, especially in premenopaus